A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life.

Int J Colorectal Dis · 2013 · PMC3587687 · PMID 22885882

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

just failed to reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

In post-treatment period, symbiotic group compared to placebo group showed a longer rectosigmoid transit time that just failed to reach statistical significance (symbiotic 14.3 ± 2.5 vs placebo group 8.9 ± 1.9 h (mean ± SE), M-W, p = 0.06), while no differences were found in total, right and left CTT.

also in 203 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.